Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Joseph Iii Klein. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Joseph Iii Klein har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:IONS / Ionis Pharmaceuticals, Inc. | Director | 0 |
Director | 0 | |
US:69329YAE4 / PDL BioPharma, Inc. Bond 2.875% | Director | 16 983 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Joseph Iii Klein. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp IONS / Ionis Pharmaceuticals, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i IONS / Ionis Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i IONS / Ionis Pharmaceuticals, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Joseph Iii Klein som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −28 000 | 0 | −100,00 | 60,00 | −1 680 000 | |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12 000 | 28 000 | 75,00 | ||||
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 16 000 | 16 000 | |||||
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −28 000 | 0 | −100,00 | 60,00 | −1 680 000 | |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12 000 | 28 000 | 75,00 | ||||
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 16 000 | 16 000 | |||||
2024-07-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 000 | 0 | −100,00 | 50,00 | −600 000 | |
2024-07-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12 000 | 12 000 | 24,42 | 293 040 | 293 040 | ||
2024-05-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −930 | 0 | −100,00 | 42,90 | −39 893 | ||
2024-05-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 070 | 930 | −53,50 | 42,55 | −45 526 | 39 569 | |
2024-05-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −731 | 2 000 | −26,77 | 42,98 | −31 416 | 85 953 | |
2024-05-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 269 | 2 731 | −31,72 | 42,59 | −54 044 | 116 306 | |
2024-05-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −682 | 4 000 | −14,57 | 42,94 | −29 288 | 171 780 | |
2024-05-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 318 | 4 682 | −21,97 | 42,57 | −56 110 | 199 323 | |
2023-11-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 16 346 | −10,90 | 50,00 | −100 000 | 817 300 |
2023-09-28 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 18 346 | −9,83 | 45,13 | −90 254 | 827 896 |
2023-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 555 | 20 346 | −14,87 | 42,00 | −149 310 | 854 532 |
2023-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 333 | 23 901 | 28,72 | ||||
2023-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 777 | 18 568 | 10,58 | ||||
2023-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 16 791 | −10,64 | 40,00 | −80 000 | 671 640 |
2022-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −644 | 18 791 | −3,31 | 38,78 | −24 974 | 728 715 |
2022-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −689 | 19 435 | −3,42 | 37,74 | −26 003 | 733 477 |
2022-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 665 | 20 124 | 15,26 | ||||
2022-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 333 | 17 459 | 43,98 | ||||
2022-02-14 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
G - Gift | 8 000 | 8 000 | |||||
2022-02-14 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
G - Gift | 12 000 | 12 000 | |||||
2022-02-14 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
G - Gift | 12 000 | 12 000 | |||||
2022-02-14 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
G - Gift | 16 000 | 16 000 | |||||
2022-02-14 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
G - Gift | 16 000 | 16 000 | |||||
2022-02-14 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
G - Gift | 12 000 | 12 000 | |||||
2022-02-14 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
G - Gift | −8 000 | 8 000 | −50,00 | ||||
2022-02-14 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
G - Gift | −12 000 | 0 | −100,00 | ||||
2022-02-14 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
G - Gift | −12 000 | 0 | −100,00 | ||||
2022-02-14 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
G - Gift | −16 000 | 0 | −100,00 | ||||
2022-02-14 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
G - Gift | −16 000 | 0 | −100,00 | ||||
2022-02-14 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
G - Gift | −12 000 | 4 000 | −75,00 | ||||
2022-02-14 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
G - Gift | 6 000 | 6 000 | |||||
2022-02-14 |
|
5 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
G - Gift | −6 000 | 12 126 | −33,10 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −1 778 | 9 775 | −15,39 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −666 | 11 553 | −5,45 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −889 | 12 219 | −6,78 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −5 333 | 13 108 | −28,92 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 334 | 18 126 | −19,30 | 35,30 | −152 989 | 639 844 |
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 778 | 22 460 | 8,60 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 666 | 20 682 | 3,33 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 889 | 20 016 | 4,65 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 333 | 19 127 | 38,66 | ||||
2021-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
A - Award | 5 333 | 18 441 | 40,69 | ||||
2021-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | |||||
2020-10-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 889 | 13 794 | −17,32 | 46,86 | −135 386 | 646 421 |
2020-10-13 |
|
4 | AKCA |
AKCEA THERAPEUTICS, INC.
Stock Option (right to buy) |
D - Sale to Issuer | −26 400 | 0 | −100,00 | 2,01 | −53 064 | ||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −667 | 666 | −50,04 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 667 | 16 683 | 4,16 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −889 | 1 777 | −33,35 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 889 | 16 016 | 5,88 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | |||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 5 333 | 5 333 | |||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 778 | 5 332 | −25,01 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −666 | 0 | −100,00 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 778 | 15 127 | 13,32 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 666 | 13 349 | 5,25 | ||||
2020-04-15 |
|
4 | AKCA |
AKCEA THERAPEUTICS, INC.
Stock Option (right to buy) |
A - Award | 26 400 | 26 400 | |||||
2019-12-23 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 0 | −100,00 | ||||
2019-12-23 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 12 683 | −7,31 | 61,87 | −61 874 | 784 750 |
2019-12-23 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 13 683 | 7,88 | 35,53 | 35 530 | 486 157 |
2019-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 1 000 | −50,00 | ||||
2019-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 12 683 | −7,31 | 65,45 | −65 446 | 830 058 |
2019-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 13 683 | 7,88 | 35,53 | 35 530 | 486 157 |
2019-12-10 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 2 000 | −33,33 | ||||
2019-12-10 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 12 683 | −7,31 | 63,74 | −63 745 | 808 474 |
2019-12-10 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 13 683 | 7,88 | 35,53 | 35 530 | 486 157 |
2019-12-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 3 000 | −25,00 | ||||
2019-12-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 12 683 | −7,31 | 64,08 | −64 083 | 812 765 |
2019-12-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 13 683 | 7,88 | 35,53 | 35 530 | 486 157 |
2019-11-26 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −812 | 12 683 | −6,02 | 62,90 | −51 075 | 797 761 |
2019-11-21 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 13 495 | −12,91 | 60,00 | −120 000 | 809 700 |
2019-09-23 |
|
4 | AKCA |
AKCEA THERAPEUTICS, INC.
Stock Option (right to buy) |
A - Award | 53 000 | 53 000 | |||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −667 | 1 333 | −33,35 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 667 | 15 495 | 4,50 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −889 | 2 666 | −25,01 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 889 | 14 828 | 6,38 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 16 000 | 16 000 | |||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 7 110 | 7 110 | |||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −667 | 666 | −50,04 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −666 | 0 | −100,00 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 667 | 13 939 | 5,03 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 666 | 13 272 | 5,28 | ||||
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −667 | 2 000 | −25,01 | ||||
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 667 | 12 606 | 5,59 | ||||
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 16 000 | 16 000 | |||||
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 3 555 | 3 555 | |||||
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −2 000 | 1 999 | −50,01 | ||||
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 000 | 11 939 | 20,12 | ||||
2018-03-30 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 2 000 | 0 | −100,00 | ||||
2018-03-30 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 9 939 | −16,75 | 46,15 | −92 300 | 458 685 |
2018-03-30 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 11 939 | 20,12 | 24,42 | 48 840 | 291 550 |
2018-03-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 2 000 | 2 000 | |||||
2018-03-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 9 939 | −1,97 | 52,11 | −10 422 | 517 921 |
2018-03-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 200 | 10 139 | 2,01 | 24,42 | 4 884 | 247 594 |
2018-03-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −900 | 9 939 | −8,30 | 51,59 | −46 431 | 512 753 |
2018-03-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 900 | 10 839 | 9,06 | 24,42 | 21 978 | 264 688 |
2018-03-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 900 | 10 839 | 9,06 | 24,42 | 21 978 | 264 688 |
2018-03-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −900 | 9 939 | −8,30 | 50,45 | −45 405 | 501 423 |
2018-03-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 3 000 | 0 | −100,00 | ||||
2018-03-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 100 | 9 939 | −17,44 | 52,29 | −109 809 | 519 710 |
2018-03-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 100 | 12 039 | 21,13 | 35,53 | 74 613 | 427 746 |
2018-03-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −900 | 9 939 | −8,30 | 51,02 | −45 918 | 507 088 |
2018-03-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 900 | 10 839 | 9,06 | 35,53 | 31 977 | 385 110 |
2018-02-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 3 000 | 3 000 | |||||
2018-02-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 600 | 9 939 | −13,87 | 49,20 | −78 720 | 488 999 |
2018-02-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 600 | 11 539 | 16,10 | 35,53 | 56 848 | 409 981 |
2018-02-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 400 | 9 939 | −12,35 | 48,76 | −68 264 | 484 626 |
2018-02-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 400 | 11 339 | 14,09 | 35,53 | 49 742 | 402 875 |
2018-01-31 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 3 000 | 6 000 | 100,00 | ||||
2018-01-31 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 9 939 | −23,19 | 52,86 | −158 580 | 525 376 |
2018-01-31 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 12 939 | 30,18 | 35,53 | 106 590 | 459 723 |
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −3 000 | 9 000 | −25,00 | ||||
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 400 | 9 939 | −12,35 | 52,97 | −74 158 | 526 469 |
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 400 | 11 339 | 14,09 | 35,53 | 49 742 | 402 875 |
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 600 | 9 939 | −13,87 | 52,13 | −83 408 | 518 120 |
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 600 | 11 539 | 16,10 | 35,53 | 56 848 | 409 981 |
2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Employee Director Stock Option (right to buy) |
M - Exercise | −3 000 | 0 | −100,00 | ||||
2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 9 939 | −23,19 | 50,56 | −151 680 | 502 516 |
2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 12 939 | 30,18 | 28,47 | 85 410 | 368 373 |
2017-12-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
NonEmployee Director stock option (right to buy) |
M - Exercise | −3 000 | 3 000 | −50,00 | ||||
2017-12-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 9 939 | −23,19 | 51,69 | −155 070 | 513 747 |
2017-12-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 12 939 | 30,18 | 28,47 | 85 410 | 368 373 |
2017-12-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −3 000 | 6 000 | −33,33 | ||||
2017-12-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 9 939 | −23,19 | 53,55 | −160 650 | 532 233 |
2017-12-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 12 939 | 30,18 | 28,47 | 85 410 | 368 373 |
2017-11-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Employee Director Stock Option (right to buy) |
M - Exercise | −2 812 | 0 | −100,00 | ||||
2017-11-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 812 | 9 939 | 39,46 | 12,94 | 36 387 | 128 611 |
2017-11-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Employee Director Stock Option (right to buy) |
M - Exercise | −2 250 | 9 000 | −20,00 | ||||
2017-11-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 250 | 7 127 | −23,99 | 53,56 | −120 510 | 381 722 |
2017-11-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 250 | 9 377 | 31,57 | 28,47 | 64 058 | 266 963 |
2017-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 7 127 | −29,62 | 55,39 | −166 170 | 394 765 |
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 16 000 | 16 000 | |||||
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 2 667 | 2 667 | |||||
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 469 | 10 127 | 32,24 | ||||
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −2 469 | 3 999 | −38,17 | ||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −312 | 0 | −100,00 | ||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 312 | 7 658 | 4,25 | ||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 16 000 | 16 000 | |||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 2 667 | 2 667 | |||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 803 | 3 801 | −32,17 | ||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 469 | 7 346 | 6,82 | ||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 667 | 6 877 | 10,74 | ||||
2016-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 667 | 6 877 | 10,74 | ||||
2015-11-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −3 125 | 2 812 | −52,64 | ||||
2015-11-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −3 750 | 0 | −100,00 | ||||
2015-11-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 125 | 5 543 | −36,05 | 64,18 | −200 561 | 355 747 | |
2015-11-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 125 | 8 668 | 56,38 | 12,94 | 40 438 | 112 164 | |
2015-11-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 750 | 5 543 | −40,35 | 64,18 | −240 673 | 355 747 | |
2015-11-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 750 | 9 293 | 67,65 | 9,30 | 34 875 | 86 425 | |
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −312 | 312 | −50,00 | ||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 312 | 5 543 | 5,96 | ||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 16 000 | 16 000 | |||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 2 667 | 2 667 | |||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −667 | 2 000 | −25,01 | ||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −469 | 937 | −33,36 | ||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 667 | 5 231 | 14,61 | ||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 469 | 4 564 | 11,45 | ||||
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −2 500 | 5 937 | −29,63 | ||||
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −3 750 | 3 750 | −50,00 | ||||
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −3 750 | 3 750 | −50,00 | ||||
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −7 000 | 4 095 | −63,09 | 70,95 | −496 682 | 290 559 | |
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 500 | 11 095 | 29,09 | 12,94 | 32 350 | 143 569 | |
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 750 | 8 595 | 77,40 | 9,30 | 34 875 | 79 934 | |
2015-03-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 750 | 4 845 | 342,47 | 9,22 | 34 575 | 44 671 | |
2015-02-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
G - Gift | −2 000 | 1 095 | −64,62 | ||||
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −313 | 624 | −33,40 | ||||
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 313 | 3 095 | 11,25 | ||||
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 16 000 | 16 000 | |||||
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 2 667 | 2 667 | |||||
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −469 | 1 406 | −25,01 | ||||
2014-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 469 | 2 782 | 20,28 | ||||
2014-01-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −2 813 | 8 437 | −25,00 | ||||
2014-01-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −7 500 | 0 | −100,00 | ||||
2014-01-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 813 | 2 313 | −54,88 | 48,61 | −136 740 | 112 435 | |
2014-01-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 813 | 5 126 | 121,62 | 12,94 | 36 400 | 66 330 | |
2014-01-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −7 500 | 2 313 | −76,43 | 48,68 | −365 098 | 112 596 | |
2014-01-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 500 | 9 813 | 324,25 | 16,32 | 122 400 | 160 148 | |
2013-11-27 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 000 | 2 313 | −72,18 | 36,86 | −221 156 | 85 256 | |
2013-08-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −7 500 | 7 500 | −50,00 | ||||
2013-08-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −7 500 | 7 500 | −50,00 | ||||
2013-08-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −3 750 | 0 | −100,00 | ||||
2013-08-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −7 500 | 8 313 | −47,43 | 28,22 | −211 650 | 234 593 | |
2013-08-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −7 500 | 8 313 | −47,43 | 28,22 | −211 650 | 234 593 | |
2013-08-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 500 | 15 813 | 90,22 | 9,22 | 69 150 | 145 796 | |
2013-08-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 500 | 15 813 | 90,22 | 9,30 | 69 750 | 147 061 | |
2013-08-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 647 | 8 313 | −30,49 | 28,22 | −102 918 | 234 593 | |
2013-08-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 647 | 11 960 | 43,87 | 13,88 | 50 620 | 166 005 | |
2013-08-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −103 | 8 313 | −1,22 | 28,23 | −2 908 | 234 676 | |
2013-08-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 103 | 8 416 | 1,24 | 13,88 | 1 430 | 116 814 | |
2013-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −313 | 937 | −25,04 | ||||
2013-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 313 | 8 313 | 3,91 | ||||
2013-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 1 875 | 1 875 | |||||
2013-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 11 250 | 11 250 | |||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −174 | 0 | −100,00 | 18,00 | −3 132 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 174 | 174 | 5,93 | 1 032 | 1 032 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 250 | 0 | −100,00 | 18,00 | −22 500 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 250 | 1 250 | 9,22 | 11 525 | 11 525 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 0 | −100,00 | 18,00 | −45 000 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 500 | 2 500 | 16,32 | 40 800 | 40 800 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −174 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −174 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −1 250 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −1 250 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −2 500 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −2 500 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −4 167 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −4 167 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −3 750 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −3 750 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −1 250 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −2 500 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −3 750 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −173 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −4 166 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 167 | 0 | −100,00 | 18,00 | −75 006 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 167 | 0 | −100,00 | 18,00 | −75 006 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 167 | 4 167 | 9,77 | 40 712 | 40 712 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 167 | 4 167 | 9,77 | 40 712 | 40 712 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 750 | 0 | −100,00 | 18,00 | −67 500 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 750 | 3 750 | 13,88 | 52 050 | 52 050 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −174 | 0 | −100,00 | 18,00 | −3 132 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 174 | 174 | 5,93 | 1 032 | 1 032 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 250 | 0 | −100,00 | 18,00 | −22 500 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 250 | 0 | −100,00 | 18,00 | −22 500 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 250 | 1 250 | 9,22 | 11 525 | 11 525 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 250 | 1 250 | 9,22 | 11 525 | 11 525 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 0 | −100,00 | 18,00 | −45 000 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 500 | 2 500 | 16,32 | 40 800 | 40 800 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 750 | 0 | −100,00 | 18,00 | −67 500 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 750 | 3 750 | 13,88 | 52 050 | 52 050 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −173 | 100 | −63,37 | 18,00 | −3 114 | 1 800 |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 173 | 273 | 173,00 | 5,93 | 1 026 | 1 619 |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 100 | −96,15 | 18,00 | −45 000 | 1 800 |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 500 | 2 600 | 2 500,00 | 16,32 | 40 800 | 42 432 |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 166 | 100 | −97,66 | 18,00 | −74 988 | 1 800 |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 166 | 4 266 | 4 166,00 | 9,77 | 40 702 | 41 679 |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 750 | 100 | −97,40 | 18,00 | −67 500 | 1 800 |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 750 | 3 850 | 3 750,00 | 13,88 | 52 050 | 53 438 |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −3 727 | 174 | −95,54 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −3 726 | 174 | −95,54 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −3 726 | 174 | −95,54 | ||||
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 727 | 0 | −100,00 | 18,00 | −67 086 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 727 | 3 727 | 5,93 | 22 101 | 22 101 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 726 | 0 | −100,00 | 18,00 | −67 068 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 726 | 0 | −100,00 | 18,00 | −67 068 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 726 | 3 726 | 5,93 | 22 095 | 22 095 | |
2013-03-21 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 726 | 3 726 | 5,93 | 22 095 | 22 095 | |
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −6 667 | 0 | −100,00 | ||||
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −6 667 | 0 | −100,00 | ||||
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −266 | 3 901 | −6,38 | ||||
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −266 | 3 901 | −6,38 | ||||
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −6 666 | 0 | −100,00 | ||||
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
M - Exercise | −268 | 3 899 | −6,43 | ||||
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 667 | 0 | −100,00 | 18,01 | −120 052 | |
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 667 | 0 | −100,00 | 18,01 | −120 052 | |
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 667 | 6 667 | 5,17 | 34 468 | 34 468 | |
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 667 | 6 667 | 5,17 | 34 468 | 34 468 | |
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −266 | 0 | −100,00 | 18,01 | −4 790 | |
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −266 | 0 | −100,00 | 18,01 | −4 790 | |
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 266 | 266 | 5,93 | 1 577 | 1 577 | |
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 266 | 266 | 5,93 | 1 577 | 1 577 | |
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 666 | 100 | −98,52 | 18,01 | −120 034 | 1 801 |
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 666 | 6 766 | 6 666,00 | 5,17 | 34 463 | 34 980 |
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −268 | 100 | −72,83 | 18,01 | −4 826 | 1 801 |
2013-03-14 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 268 | 368 | 268,00 | 5,93 | 1 589 | 2 182 |
2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 11 250 | 11 250 | |||||
2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 1 250 | 1 250 | |||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 1 250 | 1 250 | |||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 1 250 | 1 250 | |||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 2 500 | 2 500 | |||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 2 500 | 2 500 | |||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 3 750 | 3 750 | |||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 3 750 | 3 750 | |||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 4 167 | 4 167 | |||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 4 167 | 4 167 | |||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 1 250 | 1 250 | |||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 2 500 | 2 500 | |||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 3 750 | 3 750 | |||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 4 166 | 4 166 | |||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | −3 750 | 11 250 | −25,00 | ||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | −7 500 | 7 500 | −50,00 | ||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | −11 250 | 3 750 | −75,00 | ||||
2012-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | −12 500 | 0 | −100,00 | ||||
2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
G - Gift | 4 167 | 4 167 | |||||
2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
G - Gift | 4 167 | 4 167 | |||||
2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
G - Gift | 6 667 | 6 667 | |||||
2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
G - Gift | 6 667 | 6 667 | |||||
2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
G - Gift | 4 166 | 4 166 | |||||
2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
G - Gift | 6 666 | 6 666 | |||||
2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
G - Gift | −12 500 | 0 | −100,00 | ||||
2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
G - Gift | −20 000 | 0 | −100,00 | ||||
2009-06-08 |
|
4 | PDLI |
PDL BIOPHARMA, INC.
Common Stock |
A - Award | 6 983 | 16 983 | 69,83 | 7,16 | 49 998 | 121 598 | |
2007-09-10 |
|
4 | PDLI |
PDL BIOPHARMA, INC.
Commn Stock |
P - Purchase | X | 500 | 1 500 | 50,00 | 20,12 | 10 060 | 30 180 |
2005-12-15 | 3 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
100 |